German chemical and pharma group Merck KGaA has acknowledged that it is in talks to buy US biotech SpringWorks, but cautioned there is no guarantee a deal will be forthcoming. Merck said in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback